Molecular Biomarkers and Risk Prediction Models for Acute Kidney Injury Following Liver Transplantation: A Review

Area of Science:

• Nephrology
• Transplantation Medicine
• Biomarker Discovery

Background:

• Postoperative acute kidney injury (AKI) is a significant complication following liver transplantation, affecting 30%-70% of patients and negatively impacting prognosis.
• Current creatinine-based markers for AKI lack sensitivity and timeliness, hindering early diagnosis and intervention.
• Existing predictive models face challenges in clinical implementation due to inconsistent definitions and validation.

Purpose of the Study:

• To review and synthesize recent advancements in predictive models and molecular biomarkers for AKI in liver transplant recipients.
• To evaluate the performance, limitations, and translational potential of these diagnostic tools.
• To identify future research directions for improving AKI prediction and patient outcomes.

Main Methods:

• Review of existing literature on predictive models, including scoring systems, logistic regression, and machine learning algorithms (e.g., ANNs, random forest, XGBoost).
• Analysis of novel molecular biomarkers for AKI, categorizing them by detection time and biological pathway (e.g., tubular injury, cell cycle arrest, inflammation, endothelial dysfunction).
• Evaluation of the accuracy, limitations, and clinical applicability of various predictive strategies.

Main Results:

• Machine learning models demonstrate high predictive accuracy (AUC 0.75-0.91) but require further validation and standardization.
• Novel biomarkers like NGAL, KIM-1, [TIMP-2]×[IGFBP7], and cystatin C offer early detection of renal injury within hours post-transplantation.
• Emerging biomarkers targeting inflammatory and endothelial pathways show potential for enhanced predictive capabilities.

Conclusions:

• Integrating diverse biomarkers across different time points and pathways can improve AKI prediction accuracy.
• Early detection of AKI through novel biomarkers and validated predictive models is crucial for timely, stage-specific interventions.
• Further research and external validation are necessary to translate these advancements into routine clinical practice for better liver transplant outcomes.